Net cost differences were AU$4.2 billion for SGLT2is and AU$20.2 billion for GLP-1 RAs, and the ICERs were AU$23,717 and AU$100,705 per QALY gained, respectively
See the images below to compare these two mechanisms: The effects of ethanol are biphasic
Whether someone is switching treatments or completely new to GLP-1s, confidence comes from education
Direct NAD+ injections typically contain much higher doses (100-500 mg per session) and are administered intravenously rather than subcutaneously
This program focuses on how incretin-based therapies support metabolic signaling, inflammation balance, and cardiometabolic health while prioritizing tolerability and long-term adherence
But its no longer the default conversation it was before 2023